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INTRODUCTION
ErbB2 is a member of the epidermal growth factor receptor
(EGFR) family of transmembrane receptor tyrosine kinases
(Alroy and Yarden, 1997; Hynes and Stern, 1994). Although
it has no known ligand, it is commonly found in
heteroassociation with the other three members of the erbB
family, specifically the EGF (erbB1) and heregulin (erbB3,
erbB4) receptors (Karunagaran et al., 1996). The interaction
with erbB2 greatly enhances the signaling capacity of these
proteins (Tzahar et al., 1996). Mutant forms of erbB2 are
highly oncogenic due to the constitutive activation of its very
potent kinase activity (Bargmann et al., 1986). The effects of
oncogenic erbB2 on the malignant phenotype are also
determined by the nature of the homo- and heterodimers that
form in the context of a given expression pattern. ErbB2 is
overexpressed in breast cancer patients (Ahmad et al., 1993).
However, considerable controversy exists about the prognostic
value of this finding, attributable at least in part to differences
in the binding specificities and affinities of the monoclonal and
polyclonal antibodies used in clinical laboratory practice (Press
et al., 1994; Strawn and Shawver, 1998). The importance of
small- and large-scale clustering of receptors in determining
the malignant phenotype was not addressed in these studies. A
humanized monoclonal antibody against erbB2 has been in
clinical trial (Baselga et al., 1996) and just approved for patient
use.
The association of erbB receptor molecules has been
examined extensively by classical biochemical, molecular
biological (Sliwkowski et al., 1994; Tzahar et al., 1996) and
biophysical (Gadella and Jovin, 1995; Nagy et al., 1998)
techniques. Biochemical methods revealed that extensive
homo- and heteroassociation is present among members of the
erbB family (Tzahar et al., 1996), but since these methods
necessitate the isolation of proteins, they are inherently unable
to detect the association in the in vivo environment, and are
also not suitable for detecting heterogeneity within or among
cells. Fluorescence resonance energy transfer (FRET) has been
used to measure the monomer-dimer distribution of EGF
(erbB1) receptors in living cells (Gadella and Jovin, 1995), as
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ErbB2 (HER2, Neu), a member of the epidermal growth
factor (EGF) receptor tyrosine kinase family, is often
overexpressed in breast cancer and other malignancies.
ErbB2 homodimerizes but also presents as a common
auxiliary subunit of the EGF and heregulin receptors
(erbB1 or EGFR; and erbB3-4, respectively), with which it
heteroassociates. ErbB2 is generally regarded as an orphan
(ligand-less) receptor with a very potent kinase domain
activated either via its associated partners or constitutively
as a consequence of discrete mutations. It follows that the
extent and regulation of its cell surface interactions are of
central importance. We have studied the large-scale
association pattern of erbB2 in quiescent and activated cells
labeled with fluorescent anti-erbB2 monoclonal antibodies
using scanning near-field optical microscopy (SNOM).
ErbB2 was found to be concentrated in irregular
membrane patches with a mean diameter of approx. 0.5 m m
in nonactivated SKBR3 and MDA453 human breast tumor
cells. The average number of erbB2 proteins in a single
cluster on nonactivated SKBR3 cells was about 103.
Activation of SKBR3 cells with EGF, heregulin as well as a
partially agonistic anti-erbB2 monoclonal antibody led to
an increase in the mean cluster diameter to 0.6-0.9 m m,
irrespective of the ligand. The EGF-induced increase in the
erbB2 cluster size was inhibited by the EGFR-specific
tyrosine kinase inhibitor PD153035. The average size of
erbB2 clusters on the erbB2-transfected line of CHO cells
(CB2) was similar to that of activated SKBR3 cells, a
finding correlated with the increased base-line tyrosine
phosphorylation of erbB2 in cells expressing only erbB2.
We conclude that an increase in cluster size may constitute
a general phenomenon in the activation of erbB2.
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well as the heterogeneous pattern of erbB2 association in breast
tumor cells (Nagy et al., 1998). The homoassociation of erbB2
was heterogeneous in unstimulated SKBR3 breast tumor cells;
membrane areas with a mean diameter in the sub- m m range
were present, in which the extent of homoassociation was
anomalously high (Nagy et al., 1998). The implication is that
large-scale association of receptors may exist, in addition to
dimerization. Unfortunately, the resolution power of the
conventional fluorescence microscope has not permitted a
more detailed analysis of this phenomenon. In short, the
methods employed to date have been restricted to the very high
and to the very low limits of the detection scale, corresponding
to physical interactions at the level of homo- and heterodimers
or extensive molecular associations (caps and patches),
respectively.
Numerous studies directed at the plasma membrane have
provided evidence for the existence of distinct domains in the
sub-m m range (Damjanovich et al., 1995; Edidin, 1997;
Friedrichson and Kurzchalia, 1998; Hwang et al., 1998, 1995;
Jacobson et al., 1995; Jenei et al., 1997; Kenworthy and Edidin,
1998; Varma and Major, 1998; Vereb et al., 1997). These
patches are found for lipids (‘rafts’) as well as protein
molecules, the distribution patterns of which do not necessarily
overlap (Hwang et al., 1998). In the case of the major
histocompatibility complex class I (MHC-I), clusters
containing 50-100 molecules have been reported (Hwang et al.,
1998; Matkó et al., 1994).
Protein-protein interactions among erbB proteins are
important. However, the formation of large associations with
dimensions in the range of several hundred nm has been
neglected so far in the study of the erbB signaling network.
Since a local accumulation of a growth factor receptor may
enhance the efficiency of transmembrane signaling, e.g. by
providing a ‘focusing effect’, we examined the distribution of
erbB2 protein in the plasma membrane of cells and established
a correlation between the degree of clustering with the
activation state of the protein.
The FRET phenomenon is inherently very sensitive to
dimerization (Gadella and Jovin, 1995) and global surface
distribution patterns (Kenworthy and Edidin, 1998; Varma and
Major, 1998), but not to the evolution of higher order
complexes during a process such as clustering. In contrast to
FRET, the newly available technique of scanning near-field
optical microscopy (SNOM) is not limited by diffraction
optics, and one can readily image objects in the 0.1-1 m m
range, including sub-m m lipid and protein clusters in the
plasma membrane (Hwang et al., 1998, 1995; Kirsch et al.,
1996; Nagy et al., 1998; Vereb et al., 1997). In this study, we
used fluorescent anti-erbB2 antibody-labeled samples and
SNOM to detect and characterize the clustering of erbB2 on
the surface of quiescent and activated cells. ErbB2 formed very
conspicuous patches in the plasma membrane of two different
breast tumor cells (SKBR3 and MDA453), the mean diameter
of which was approx. 0.5 m m. Cluster formation may be a
general property of erbB2, since it was also present in the
plasma membrane of erbB2-transfected CHO cells. However,
the size of the erbB2 clusters was considerably larger in these
cells. We attribute this finding to the higher baseline tyrosine
phosphorylation (activation) level of erbB2 in cells expressing
only erbB2, inasmuch as activation of SKBR3 breast tumor
cells with EGF, heregulin and a partially agonistic antibody
(4D5) also resulted in an increase in cluster size. The causal
relationship between activation of erbB signaling and increased
cluster size was further corroborated by the finding that the
EGF-induced effect on the mean size of erbB2 clusters was
blocked by the EGF receptor-specific quinazoline-based
PD153035 tyrosine kinase inhibitor.
MATERIALS AND METHODS
Cell lines
Human breast tumor cell lines SKBR3 and MDA453 were obtained
from the American Type Tissue Culture Collection (Rockville, MD)
and grown according to specified protocols to confluency on the
surface of glass coverslips. CB2 cells generated by transfecting erbB2
into Chinese Hamster Ovary (CHO) cells (Tzahar et al., 1996), were
kindly provided by Y. Yarden (Weizmann Institute, Rehovot, Israel).
Antibodies and calibration microspheres
Two antibodies directed against non-overlapping extracellular
epitopes on erbB2 (4D5, 7C2) were a generous gift of Genentech
(Genentech Inc., South San Francisco, CA) (Fendly et al., 1990).
Monovalent Fab fragments were generated from the 4D5 antibody as
described previously (Nagy et al., 1998). Samples of purified
monoclonal antibodies or Fab fragments were labeled with 5-(and 
6-)carboxytetramethylrhodamine succinimidyl ester (TAMRA-SE,
Molecular Probes, Eugene, OR) according to standard protocols
provided by the manufacturer. The dye:protein ratio was 3:1 and 1:1
in the case of antibodies and Fab fragments, respectively, and was
determined by spectrophotometric methods. Fluorescently-tagged
antibodies and Fab fragments retained their binding capacity,
according to competition assays with identical, but unlabeled
antibodies.
The integrated fluorescence intensity of single erbB2 clusters was
quantitated by comparison with Rainbow Calibration Particles
(Spherotech Inc., Libertyville, IL).
Labeling of cell-surface antigens
Cells were used for labeling and SNOM and confocal microscopic
imaging on the surface of glass coverslips without trypsinization (in
situ labeling). They were washed twice in phosphate-buffered saline
(PBS), and labeled with a saturating concentration of a monoclonal
antibody or Fab fragment for 30 minutes on ice in the dark. Excess,
unbound monoclonal antibody or Fab fragment was removed by
washing the cells twice in ice-cold PBS. Cells for SNOM imaging were
then fixed in 4% paraformaldehyde for 60 minutes on ice, and
dehydrated in an ethanol series. Experiments with a confocal
microscope were carried out with non-dehydrated cells that were either
unfixed or mildly fixed in 1% paraformaldehyde for 30 minutes on ice.
Activation of cells with EGF, heregulin and 4D5 antibody
Cells were treated with 50 ng/ml EGF or 50 ng/ml heregulin (the
EGF-like domain of heregulin alpha, R&D Systems, Abingdon, UK)
in situ on the surface of coverslips. Cells were kept in a CO2 incubator
at 37°C for 30 minutes in medium without serum in the presence of
the activating agents. Cells were then washed twice in PBS, and
labeled with fluorescent antibodies as described above.
Activation with the 4D5 antibody was carried out as follows. Cells
were incubated in the presence of a saturating concentration of
TAMRA-labeled 4D5 antibody for 30 minutes at 37°C in a CO2
incubator in medium without serum. Then cells were washed twice in
PBS, fixed and dehydrated as described above, and imaged with the
SNOM. In this case, the activating and the labeling antibodies were
the same. In another protocol we used a saturating concentration of
unlabeled 4D5 antibody as the activating agent. After incubating the
cells in the presence of unlabeled 4D5 for 30 minutes at 37°C in the
CO2 incubator in medium without serum, cells were washed twice in
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PBS, and labeled with TAMRA-labeled 7C2 anti-erbB2 antibodies as
described above. Afterwards these cells were also fixed and
dehydrated before imaging. Since 4D5 treatment induces
internalization of erbB2 (Sarup et al., 1991), this second protocol
ensured that the fluorescent labels were restricted to the extracellular
surface of cells, i.e. were not binding to endocytotic vesicles.
Treatment of cells with kinase inhibitor
The quinazoline-based PD153035 tyrosine kinase inhibitor (4-[(3-
bromophenyl)amino]-6,7-dimethoxyquinazoline) was purchased from
Calbiochem (Bad Soden, Germany). Because of the low aqueous
solubility, a stock solution (2 mM) was prepared in THF and diluted
before treatment. Cells were exposed in the presence of PD153035 in
1 m M final concentration for 5 minutes at 37°C in a CO2 incubator in
medium without serum. The EGF activation was carried out in the
presence of the inhibitor specified above. 
Scanning near-field optical microscopy (SNOM)
The SNOM was an add-on to a Nanoscope-IIIa scanning probe system
(Digital Instruments, Santa Barbara, CA) (Kirsch et al., 1998a).
Simultaneous excitation and detection of fluorescence emission were
with an uncoated optical fiber tip (Bielefeldt et al., 1994; Courjon et
al., 1990; Kirsch et al., 1998a,b). The tips were produced with a
commercial pipette puller (P-2000, Sutter Instruments, Novato, CA)
from a 9 m m core diameter optical fiber (SMF 1528 CPC6, Siecor,
Neustadt, Germany) and mounted in a shear force sensor head
developed in our laboratory (Kirsch et al., 1997). Excitation of the
TAMRA-labeled monoclonal antibodies was with the 543 nm line of
an He-Ne laser (LHGP 0101, Research Electro Optics, Boulder, CO).
Fluorescence was detected through a 488/543 nm dichroic mirror
(Chroma Techn., Brattleboro, VT) and a SWP 605/55 nm bandpass
filter (Chroma Techn.). In addition, a 630/30 nm bandpass filter
(Omega Optical Co., Brattleboro, VT) was included to block stray
light from the red diode laser used for shear force detection.
Image analysis
Cluster size analysis was performed by three different techniques.
Method 1
The cluster diameter of clusters (also referred to as particles below)
was determined manually after judiciously positioning the cursor on
the screen on opposing edges of the fluorescent region. Frequency
histograms were constructed from at least 200 such data points. 
Method 2
The original image was low-pass filtered and divided into the original
image, thereby obtaining an image lacking most background intensity
variations (Hwang et al., 1998). The resultant image was segmented
using the entropy threshold algorithm of Scil-Image (Technical
University of Amsterdam, The Netherlands). The distribution of
particle sizes on this binary mask image was determined by
ScionImage (Scion Corp., Frederick, MA). A frequency histogram
was generated from cluster areas comprising at least 200 particles.
Method 3
Normalized two-dimensional spatial autocorrelation functions
(Hwang et al., 1998) were computed by taking the inverse Fourier-
transform of the two-dimensional power spectrum matrix of the
original image. The rotation-invariant autocorrelation function was
obtained by averaging overall angles of the spatial lag vector, and
fitted to the formula: 
where g( x ) is the angle-averaged autocorrelation function, x is the
spatial lag vector, i and x i is the characteristic radius, which serves as
an adequate measure of the mean size of a single class of clusters
(Hwang et al., 1998). Fitting was carried out with Microcal Origin v.5
(Microcal Software Inc., Northampton, MA). The best fits were
obtained using two different characteristic radii. One of the terms was
taken as a measure of the average cluster size, since its value was in
the range of the directly observed clusters. We attributed the second
term with values of 2-5 m m to a low frequency trend in the background
fluorescence intensity or to clustering of clusters; it was consequently
not considered further in the interpretation of results.
The fluorescence color-coded surface plots were generated with
SXMImage (Swiss Center for Electronics and Microtechnology, Inc.,
Neuchatel, Switzerland).
Confocal microscopy
A Zeiss LSM410 confocal laser scanning microscope system was
uesd to image non-dehydrated SKBR3 cells. Excitation of TAMRA-
labeled monoclonal antibodies was carried out with the 543 nm line
of a HeNe laser. Detection of fluorescence was through a 560 nm
dichroic mirror and a 570 nm long-pass filter.
RESULTS AND DISCUSSION
SNOM reveals erbB2 clusters in quiescent SKBR3
cells
We have previously characterized the clustering of erbB2 on
SKBR3 breast tumor cells using flow and image cytometric
energy transfer measurements (Nagy et al., 1998). The SKBR3
cell line overexpresses erbB2 (~106 molecules/cell), but EGFR
and erbB3 are present at non-amplified levels (~105) (Beerli et
al., 1995). In the current work the same fluorescent monoclonal
antibodies and a SNOM were used to characterize the
distribution of erbB2 on the surface of resting and activated cells.
Quiescent SKBR3 cells were labeled with TAMRA-tagged
anti-erbB2 antibodies and imaged with the SNOM (Fig. 1). The
distribution of erbB2 was conspicuously uneven (Fig. 1B); the
fluorescence of the TAMRA-labeled monoclonal antibodies
was concentrated in membrane patches with a diameter of ~0.5
m m (Table 1). The shear-force topography (Fig. 1A) and the
fluorescence (Fig. 1B) images were merged into a composite
three-dimensional representation in which height represents
vertical displacement (topography) and superposed color
(black increasing to bright) the fluorescence intensity (Fig. 1C).
A significant tendency for the fluorescence to be greater at the
‘peaks’ and ‘ridges’ is apparent, implying that clustered
receptors located in such regions would be most exposed to the
extracellular milieu. We note that the SNOM technique is
unique in its ability to render minute topographical features in
combination with probe-specific fluorescence. A higher
resolution image (rendered as top view) of quiescent SKBR3
cells is shown in Fig. 2A. The calculation of the mean
fluorescence intensity of a cluster-free plasma membrane
indicated that approx. 60% of the total fluorescence originated
from clusters. The background intensity of unstained control
cells was negligible compared to fluorescent antibody-labeled
cells (data not shown).
As a next step we determined the size distribution of erbB2
clusters on the surface of quiescent SKBR3 cells. Following
method 1 (Materials and methods), the diameter of single
clusters was measured manually and a frequency distribution
generated (Fig. 3). The erbB2 clusters on SKBR3 cells had a
mean diameter of 0.48±0.08 m m, a value close to that reported
earlier for another transmembrane receptor protein, MHC-I
gi(x ) exp[- (x /x i)2]g(x ) =
i^
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(Hwang et al., 1998). We segmented the images (method 2)
and determined the frequency distribution of ‘particle’ sizes
(Fig. 4). The results provided by this approach (mean cluster
area: 0.27±0.12 m m2, corresponding to the diameter of an
equivalent circle of 0.59±0.16 m m) were in good agreement
with those obtained by method 1. In method 3 we calculated
the spatial autocorrelation image of TAMRA-4D5-stained
SKBR3 cells (Fig. 5). One component of the fit to the angle-
averaged autocorrelation function (characteristic radius of
0.36±0.08 m m) was close to the cluster diameter obtained by
the previous two methods. The other component, which was
also present in background-corrected images, was 2-5 m m and
probably reflected low frequency trends in the fluorescence
image. The value of this characteristic radius did not depend
on cell type or activating condition and was therefore neglected
in the interpretation of the results.
Labeling of cell surface antigens might generate
crosslinking even if labeling is carried out on ice in the
presence of excess antibody to ensure at least partly
monomeric binding. To exclude this possibility we labeled
quiescent SKBR3 cells with TAMRA-tagged 4D5 Fab
fragments (Fig. 2B, Table 1). The observed diameter of erbB2
clusters did not differ from that observed with whole
antibodies. In addition, we also tested whether crosslinking of
4D5 antibodies with TAMRA-labeled secondary antibodies
had any effect on the cluster size. None was observed,
presumably because labeling was carried out on ice (data not
shown). We conclude that cluster diameter is not altered by the
use of whole antibodies.
It has been reported that about 25-125 MHC-I are found in
a single cluster (Hwang et al., 1998). This finding prompted us
to determine the number of clustered erbB2 molecules in
nonactivated SKBR3 cells. The first approach directed at the
imaging of single antibody molecules did not succeed, possibly
due to the lower collecting efficiency of our shared aperture
SNOM system compared to instruments incorporating high
numerical aperture objectives. Based on the assumption that if
the antibodies could not be visualized, i.e. that their signal was
in the range of the standard deviation, we estimated that about
2000 erbB2 proteins could be present in a cluster. As a second
approach we used standard fluorescent microspheres to
calibrate the fluorescence intensity of a single erbB2 cluster.
The mean diameter of the beads was 2.5 m m, implying that
their total volume was not imaged by the SNOM, for which
the 1/e decay length in fluorescence detection is ~0.6 m m
(Kirsch et al., 1998c). Since the fluorochromes were distributed
evenly in the beads, we estimated that ~20% of the total
nominal integrated fluorescence intensity of a given bead was
detected. The bead sample consisted of microspheres with six
graded, calibrated fluorescence levels, expressed in R-
phycoerythrin (R-PE) equivalent units.
We measured the emission spectra of TAMRA and the bead
and the excitation spectra of R-PE and TAMRA. Correcting for
the transmission and reflectance profiles of the filters and
dichroic mirrors, respectively, as well as the labeling
stoichiometries of the antibodies, we established a calibration
curve for the determination of the number of TAMRA
molecules in a single cluster. On this basis we concluded that
about 103 erbB2 proteins are present in a single cluster. A third,
independent estimation of the number of erbB2 protein
molecules/cluster was made from the determination that the
number of erbB2 clusters is 300-400 on unactivated SKBR3
cells, assuming a homogeneous surface distribution. Confocal
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Table 1. Determination of erbB2 cluster diameter on
quiescent and activated cells
Manual Segmentation Autocorrelation
Cells and treatments (m m) (m m) (m m)
SKBR3
Quiescent 0.48±0.08 0.59±0.16 0.36±0.08 
Quiescent, labeled with Fab 0.45±0.08 0.62±0.07 0.42±0.12
4D5-activated 0.62±0.11* 0.75±0.26* 0.63±0.21*
EGF-activated 0.60±0.11* 0.8±0.31* 0.60±0.12*
EGF-treated, in the presence 0.39±0.09 0.49±0.12 0.29±0.06
of PD153035
Heregulin-activated 0.66±0.14* 0.86±0.31* 0.84±0.20*
MDA453
Quiescent 0.51±0.09 0.61±0.18 0.40±0.08
CB2
Quiescent 0.83±0.13* 0.95±0.31* 0.71±0.18*
Cells were stained with TAMRA-labeled anti-erbB2 monoclonal antibodies
or with Fab if indicated, and activated with the indicated agents as described
in Materials and methods. 
Manual (method 1): determination of cluster size by measuring the
diameter of particles on the screen.
Segmentation (method 2): entropy thresholding of background-filtered
images. 
Autocorrelation (method 3): determination of the angle-averaged
autocorrelation function of the images. 
Indicated values are means ± s.d. of at least three different experiments.
Asterisks indicate significant difference (P<0.05) from untreated SKBR3 cells
using Student’s t-test.
Fig. 1. SNOM images of quiescent SKBR3 cells stained with TAMRA-tagged anti-erbB2 (4D5). (A) Shear force topography.
(B) Immunofluorescence. (C) Composite topography (height) and fluorescence (color coded) data. See text for details.
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microscopy did not reveal significant differences in the density
of erbB2 clusters in the exposed and surface-attached plasma
membranes (data not shown). Since the number of erbB2 on a
single SKBR3 cell is about 106 (Sarup et al., 1991), there
should be around 1500-2000 erbB2 per cluster, based on our
determination that ~60% of the fluorescence signal originates
from the clusters.
We conclude that in addition to small-scale association of
erbB2 on quiescent SKBR3 cells (e.g. the presence of direct
protein-protein contacts revealed by resonance energy
transfer), there is evidence for the large-scale clustering of this
protein. Since the number of erbB2 proteins in a single cluster
is quite large, it is plausible that proteins are not held together
solely by direct erbB2-erbB2 interactions, but that lipid
domains and extra-membrane constraints are also involved. It
is also unknown how small erbB2 associations (e.g. dimers,
trimers) are organized within a cluster. Inasmuch as the
diameter of the clusters was not influenced by the labeling
conditions (primary antibody or Fab, or secondary antibody),
we infer that the clusters were not generated by extraneous
antibody generated crosslinking. Future near-field energy
transfer measurements of the homoassociation of erbB2 should
clarify this point.
ErbB2 clustering in other cell lines
Since cell-surface distribution of a membrane protein may be
cell-type dependent, we tested whether the large-scale
clustering of erbB2 is also present in the context of other
membrane proteins or if it is peculiar to SKBR3 cells. We
chose another breast tumor cell line (MDA453), which
expresses the complete erbB family (erbB1-4) except erbB1 at
a level of about 105 copies/cell. MDA453 breast tumor cells
were stained with the TAMRA-4D5 antibody according to
the same protocol employed with SKBR3 cells (Fig. 2G).
Although the signal intensities of the patches were much lower
in these compared to SKBR3 cells (reflected in the higher
relative background in image Fig. 2G), the dimension of the
clusters on MDA453 was comparable to that of SKBR3 cells
according to all three methods of analysis (Table 1; Figs 3, 4).
Since the number of erbB2 proteins in single SKBR3 and
MDA453 cells is different, as is the number of erbB2
molecules in clusters on SKBR3 and MDA453 cells, we
conclude that the cluster size was independent both of the total
number of erbB2 proteins expressed per cell and the number
of erbB2 molecules in a single cluster.
As a next step we chose an erbB2-transfected CHO cell line
(CB2) to establish whether clustering is an inherent property
of erbB2. CHO cells lack endogenous expression of erbB1,
erbB3 and erbB4, and express only a small number of erbB2
molecules (Tzahar et al., 1996). Thus, the only member of the
erbB family in CB2 cells is erbB2. In comparison to the other
cell lines, the size of the erbB2 clusters in CB2 was
significantly larger (Table 1; Figs 2H, 3, 4), although the
expression level of erbB2 in CB2 is lower than in MDA453
cells. According to method 1 (Fig. 3) the cluster population
distribution on CB2 cells was shifted to higher values, whereas
the analysis by method 2 (Fig. 4) yielded a more pronounced
overlap between the frequency histograms of SKBR3 and CB2
cells. This discrepancy is probably attributable to the different
sensitivities of the two methods with respect to edge detection.
Fig. 2. SNOM images of TAMRA-tagged anti-erbB2 labeled quiescent and activated cells. (A) Quiescent SKBR3 cells stained with TAMRA-
4D5 antibody. (B) Quiescent SKBR3 cells stained with TAMRA-4D5 Fab. (C) Unlabeled 4D5-activated SKBR3 cells labeled with TAMRA-
tagged 7C2 antibody. (D) EGF-activated SKBR3 cells stained with TAMRA-4D5 antibody. (E) SKBR3 cells stimulated with EGF in the
presence of PD153035. (F) Heregulin-activated SKBR3 cells stained with TAMRA-4D5 antibody. (G) Quiescent MDA453 cells stained with
TAMRA-4D5 antibody. (H) Quiescent CB2 cells stained with TAMRA-4D5 antibody.
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It has been reported that when erbB2 is expressed on its
own, the constitutive basal tyrosine phosphorylation level of
the protein increases compared to the situation prevailing
when the other members of the erbB family are co-expressed
(Tzahar et al., 1996; Wallasch et al., 1995). This phenomenon
is possibly caused by the competition of other erbB proteins
associating with erbB2. Since erbB2 has the highest baseline
tyrosine kinase activity, the heteroassociation of erbB2 with
other proteins at the expense of erbB2 homoassociation
should reduce the activation of this protein. Thus, we
tentatively propose that the constitutively larger cluster size
in CB2 cells reflects the higher baseline activation state of
erbB2 in these cells, compared to SKBR3 and MDA453.
Furthermore, as the number of erbB2 molecules in an average
cluster on CB2 cells was only about 2% of that in SKBR3
clusters, we infer that it is the dimension of a cluster, and not
the number of erbB2 protein it encompasses, that correlates
with the activation state of erbB2. The further implication is
that other associated proteins (receptors, protein kinase
substrates, downstream effectors) are also involved. Since the
clustering of erbB2 was present on cell lines with completely
different complements of membrane proteins, we presume
that the patchy distribution of erbB2 is an inherent property
of the receptor.
ErbB2 clustering as a function of activation and
activation agent
To further correlate the activation state of erbB2 with the
distribution pattern of the receptor, we activated SKBR3 cells
with three different agents (4D5 antibody, EGF and heregulin).
The 4D5 antibody is a partial agonist of erbB2 that induces
tyrosine phosphorylation and down-regulation of erbB2 (Sarup
et al., 1991). EGF and heregulin are known to directly or
indirectly activate erbB2 and induce tyrosine phosphorylation
of the protein (Holmes et al., 1992; Karunagaran et al., 1996;
Nagy et al., 1998; Sliwkowski et al., 1994; Tzahar et al., 1997;
Wallasch et al., 1995). We activated SKBR3 cells with EGF in
the absence of serum for 30 minutes. Cells were only labeled
afterwards to ensure that any fluorescence originated from the
plasma membrane, and not from intracellular vesicles
containing internalized erbB2 (Fig. 2D). EGF led to an increase
in the size of erbB2 clusters according to each of the evaluation
methods applied (Table 1, Figs 3, 4). Heregulin activation was
carried out on SKBR3 cells in the absence of serum. The
treatment also induced an increase in the size of erbB2 clusters
(Figs 2F, 3, 4, 5; Table 1). However, heregulin-induced
activation shifted the entire cluster population towards larger
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Fig. 3. Distribution of erbB2 cluster diameter in quiescent and
stimulated cells. Quiescent (A) and heregulin-activated (B) cells
were stained with TAMRA-labeled 4D5 antibodies, and the diameter
of clusters was determined by measuring the distance between
opposite edges of a particle (method 1). Frequency distributions were
made from at least 200 clusters from 3 independent experiments.
Fig. 4. Distribution of erbB2 cluster area in quiescent and activated
cells. Quiescent (A) and heregulin-activated (B) cells were treated
with TAMRA-labeled 4D5 antibodies, and the area of clusters was
determined by automatic segmentation of background-corrected
images (method 2). Frequency distributions of at least 200 clusters
from 3 independent measurements are presented. The histograms of
heregulin- and EGF-activated cells were similar to that of 4D5-
activated cells and are therefore omitted for clarity.
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diameters, whereas in the case of the EGF ligand, some clusters
were seemingly unaffected by exposure to the growth factor
(Fig. 3). With the analysis according to method 3, the
distinction between the two ligands was not so obvious. The
automatic and manual segmentation procedures yield divergent
results presumably due to differences in edge identification.
However, the general tendency towards an increased erbB2
cluster diameter/area was universally present.
We also activated SKBR3 cells with the partially agonistic
antibody, 4D5. In the first case, cells were activated with
TAMRA-4D5 antibodies, and imaged in the SNOM without
any further labeling, after fixation and dehydration. Although
erbB2 is thought to be down-regulation deficient, it is slowly
internalized (Baulida et al., 1996). In addition some
controversy exists about the internalization of heregulin; some
authors claim that it is not endocytosed (Baulida and Carpenter,
1997), while others find evidence for a quick translocation to
the nucleus (Li et al., 1996). However, the assumption that the
4D5 antibody induces internalization of erbB2 is generally
accepted (Sarup et al., 1991). Since SNOM can also register
fluorescence from the far field albeit with diminished efficiency
(Betzig and Chichester, 1993), the detected fluorescence may
have had a partial contribution from internalized erbB2
proteins located in endocytotic vesicles underlying the plasma
membrane. Therefore, in a second alternative procedure, cells
were first activated with unlabeled 4D5 antibody and then
stained with TAMRA-7C2 antibody, ensuring that any patchy
appearance of fluorescence was not the result of erbB2
accumulation in intracellular vesicles (Fig. 2C). The results
were the same using both staining protocols. In addition, we
established that the staining patterns of nonactivated SKBR3
cells were similar upon labeling with TAMRA-4D5 or
TAMRA-7C2 antibodies (data not shown), confirming that
patterning was not specific for a particular antibody. As with
EGF and heregulin, exposure of SKBR3 cells to the 4D5
antibody also caused an increase in the erbB2 cluster size
distribution (Figs 2C, 3, 4, Table 1). The mean number of
erbB2 proteins in a single cluster increased approximately
threefold with all of the activators on the surface of SKBR3
cells.
The influence of kinase inhibitor on the EGF-
induced effect on erbB2 cluster size
In order to establish a direct link between increased tyrosine
kinase activity and cluster size, we determined the size of
erbB2 clusters in SKBR3 cells stimulated with EGF in the
presence of PD153035, which specifically inhibits the tyrosine
kinase activity of EGFR (Fry et al., 1994). Transmembrane
signaling through the EGF receptor is markedly inhibited in
the absence of tyrosine kinase activity of the protein (Fry et al.,
1994). According to our results, the EGF-induced increase in
the erbB2 cluster size was blocked by the inhibitor (Table 1,
Fig. 2E). EGF primarily activates erbB1 tyrosine kinase
activity, and erbB2 is only activated by secondary dimerization
with the activated EGF receptor (Gamett et al., 1997). In the
absence of EGF receptor tyrosine kinase activity the whole
cascade phenomenon is inhibited (Gamett et al., 1997). The
ability of the EGF receptor tyrosine kinase inhibitor to block
erbB2 activation and increased cluster size further corroborates
the link between receptor activation and increased large scale
association.
Imaging of non-dehydrated SKBR3 cells with a
confocal microscope
Although it has previously been shown that dehydration in
itself does not influence the cluster size of membrane proteins
(Hwang et al., 1998), we tested whether large-scale association
of erbB2 is also present in cells kept under their near-
physiological conditions. Quiescent SKBR3 cells were labeled
with TAMRA-4D5 antibody, and imaged in the confocal laser
scanning microscope without dehydration (Fig. 6). Inasmuch
as results obtained with cells fixed with 1% formaldehyde were
not significantly different from those of unfixed samples, we
routinely used fixed cells during our experiments. Our results
clearly indicate that erbB2 forms conspicuous clusters in non-
dehydrated cells as well, the size of which coincided with that
found in dehydrated cells. Since the lateral and axial resolution
power of our confocal system was approximately 300 nm and
800 nm, respectively, a rigorous investigation of cluster size in
quiescent and activated cells was not possible.
Concluding remarks
The ligand-induced formation of homo- and heterodimers
among transmembrane proteins, and especially among
members of the erbB family, is well established (Hynes and
Stern, 1994; Weiss and Schlessinger, 1998). However, evidence
has been reported for an intrinsic association of erbB1, the
modulation of which by ligand is the process inducing
activation of the receptor tyrosine kinase (Gadella and Jovin,
1995). In the present SNOM study, we demonstrate the large-
scale clustering of the orphan erbB2 protein on the surface of
quiescent and activated breast tumor cells, as well as on the
surface of cells (CB2) ectopically expressing a transfected
erbB2 protein. We confirmed the presence of erbB2 clusters in
quiescent breast tumor cells with confocal microscopy of
normally hydrated cells. The physical and chemical forces
giving rise to such domains are under intensive investigation
(Edidin, 1997; Friedrichson and Kurzchalia, 1998; Jacobson et
al., 1995; Kusumi and Sako, 1996; Varma and Major, 1998).
Fig. 5. Angle-averaged autocorrelation functions of quiescent and
heregulin-activated SKBR3 cells. Quiescent (s) and heregulin-
activated (d) SKBR3 cells were stained in situ with TAMRA-4D5
antibody. The angle-averaged autocorrelation function of the images
was calculated. Data points were fitted to equation 1 (method 3). The
fitted lines are also shown.
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One presumes that numerous intracellular and extracellular
constraints and forces (e.g. interaction of cell surface proteins
with the cytoskeleton or extracellular matrix) acting in and
normal to the plane of the membrane influence the size and
distribution of these clusters. In the case of the classical EGF
receptor, one of these factors, interaction with the cytoskeleton,
clearly has an important role in regulating the kinase activity
of the protein (Gronowski and Bertics, 1993, 1995), pointing
to the possible role of clustering in regulating cellular
responses to growth factors.
The size of clusters seems to correlate with the activation
state of erbB2. Large-scale clustering has also been described
for other proteins in the plasma membrane (see Introduction).
Since the activation of the erbB signaling network is
accompanied by extensive interactions between receptors, their
substrates and downstream effectors, it is probable that the
concentration of erbB2 in clusters increases the efficiency of
transmembrane signaling. A random distribution of a given
number of erbB2 proteins in the membrane would decrease the
local concentration of erbB2, and thereby increase the diffusion
time required for generating direct receptor-receptor contact.
Thus, clustering of signal transducing proteins may serve to
decrease the lag time of activation. The size of erbB2 clusters
increased with all the activation agents, and was even larger in
quiescent CB2 cells, in which erbB2 exists in a pre-activated
state. In addition, the EGF-induced increase in cluster size was
dependent on the tyrosine kinase activity of the receptors, since
it could be blocked with an EGF receptor-specific tyrosine
kinase inhibitor. These findings argue for a general role of
increased cluster size in erbB2-mediated signal transduction or,
in the oncogenic state, aberrant and persistent mitogenic
stimulation. The increased size probably reflects a recruitment
of erbB2 and other proteins, potentiating synergistic effects.
The process of receptor dimerization may be distinct from the
formation of large-scale clusters in the sub-m m range
containing hundreds of molecules. Both events may participate
but have distinct roles in the activation of and downstream
signaling by the receptors. According to one possible scenario,
the first part in the two-step activation of the erbB signaling
network is dimerization, which initiates receptor
transphosphorylation. ErbB2 and other proteins are then
recruited into the clusters, resulting in increased cluster size
and high local concentration of signaling proteins. Although
the exact composition of these protein clusters is unknown, we
presume that they also contain other receptors, tyrosine kinase
substrates and downstream effectors, and other ‘structuring’
elements like integrin or tetraspan molecules (Szöllo˝si et al.,
1996). The precise mode of cell activation is determined by the
composition of clusters, which is in turn influenced by the
activating ligand. This point is under investigation with
spectroscopic methods sensitive for co-expression and protein-
protein interactions. Studies directed at the other erbB proteins
in these clusters on the surface of quiescent and activated cells
will shed light on another dimension of complexity in the
network of interacting erbB proteins.
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